After a 10-year process, the compromise text of the new EU General Pharmaceutical Legislation (GPL or Pharma Package) has been published and will soon become law. This blog post discusses the 10 most important changes for company pipelines, transition mechanisms, interaction with other laws, and next steps, and concludes that best efforts will be required
Latest Post
More Posts
EU Pharma Package: Sharp New Tools With Limited Protections
Will the EU Become the Most Attractive Place for Life Sciences? How the EU Woos Biotech
European Court of Justice Judgment Relating to Orphan Market Exclusivity
Are the revisions to the EU’s ‘Bolar’ system compatible with TRIPS?
Subscribe: Subscribe via RSS
Blogs
Firm/Org